Polymarket Revenue Hits $1.8B as Sports Trading Surges

Polymarket’s annualized revenue has crossed $1.8 billion as more people use its U.S. exchange to trade on the outcomes of real-world events. 

The company told CNBC on Tuesday, November 10, 2026, that its revenue run rate had reached the new milestone, supported by rising trading activity across sports and other prediction markets.

In short, this figure represents a sharp increase from June, when Polymarket disclosed that its annualized revenue had passed $1 billion. Much of this growth has reportedly come from its U.S. exchange, which operates separately from its international decentralized finance (DeFi) platform.

Sports events bring more traders to Polymarket

One of the main reasons behind the increase is the growing interest in sports-related prediction markets. Events such as the FIFA World Cup during the summer and the start of the National Football League (NFL) season in September brought more activity to the platform.

Instead of simply placing bets through a traditional sportsbook, Polymarket users can trade contracts based on what they think will happen in an event. These contracts allow traders to take positions on different possible outcomes.

Combo event contracts have also become popular. They work much like parlays in sports betting, allowing users to combine several predictions into one contract. For example, a trader could combine predictions about multiple outcomes in a sporting event instead of trading on just one result.

According to CNBC, these Combo contracts accounted for more than 70% of the platform’s trading volume on Sunday. Their popularity has helped increase the amount of activity taking place on the U.S. exchange.

U.S. exchange expansion supports revenue growth

Polymarket’s domestic exchange has played an important role in its recent growth. According to CNBC, the company opened the platform to the public in December under restricted access before removing its mobile app waitlist in mid-May.

By making the exchange easier to access, Polymarket widened the number of people who could participate in its prediction markets. This came shortly before the company reported an annualized revenue run rate above $1 billion in June.

The company is also looking to raise another $1 billion in funding at a reported valuation of $21 billion. This would give Polymarket additional funding as it expands its business.

Regulatory and security challenges remain

However, despite this surge in revenue, the platform is still dealing with several issues that could attract more attention from regulators.

For instance, the U.S. Commodity Futures Trading Commission (CFTC) has reopened an investigation into whether the company broke its 2022 agreement to prevent U.S. residents from using its international exchange. Reuters reported that investigators are examining how Polymarket checks users’ locations, alongside its advertising and customer onboarding practices.

In addition, the platform also suffered a security incident on October 29 after one of its third-party providers was compromised. 

Trading is now fully back online.

We’ll make this right and are fully reimbursing all affected traders.

— Polymarket Traders (@PolymarketTrade) October 29, 2026

Polymarket temporarily stopped trading while investigating the issue before restoring activity. The company promised to fully reimburse affected traders, saying, “Anyone who has been impacted will be made whole.”

Separately, the company reportedly dismissed its former Chief Marketing Officer, Matthew Modabber, following an internal investigation into an influencer-marketing campaign involving simulated trading activity and payments to creators. The New York Post reported the development, although the investigation’s findings were not made public.

Polymarket has previously said it is willing to cooperate with lawmakers as they examine the prediction market industry. A company spokesperson told CNBC, “We welcome scrutiny.”

Also Read: Binance Blocks MEXC Transfers After FinCEN Flags Money Laundering Concerns